|Venture Round, 8/2011 ||$49M|
|Partial Close, 7/2013 |
New Enterprise Associates
Johnson & Johnson Development Corporation
Kleiner Perkins Caufield & Byers
NeuroPace, Inc. designs, develops, manufactures, and markets implantable devices for the treatment of neurological disorders. It offers responsive Neurostimulator system (RNS) for the treatment of medically refractory partial epilepsy. The company’s RNS system consists of implantable components, including RNS neurostimulator that delivers a short train of electrical pulses to the brain, and depth leads and cortical strip leads; and external products, such as the programmer, a laptop computer with proprietary software that has a wand and telemetry interface enabling communication with an implanted RNS neurostimulator.
NeuroPace, Inc. was incorporated in 1997 and is based in Mountain View, California.